PrimeRFP SCOUT · Federal Contract Recompete Brief

75A50120C00001Antibiotic for treatment of a biothreat — Paratek Pharmaceuticals, Inc

Paratek Pharmaceuticals, Inc holds $40.7M across 2 federal awards, concentrated at Department of Health and Human Services (HHS). Competition previously drew 4 offers. Set-aside status: NONE. Recompete timing centers on the Dec 17, 2029 PoP end — agencies typically plan 12–18 months ahead.

Barda - Aspr / Daappo / Barda Dcma
Awarding office
Department of Health and Human Services (HHS)
Agency
Paratek Pharmaceuticals, Inc
Recipient
Dec 17, 2029
PoP end
$108.7M
Obligated
541714
NAICS
6505
PSC
NONE
Set-aside
4 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

NONE
Contract number75A50120C00001
AgencyDepartment of Health and Human Services (HHS)
Awarding officeBarda - Aspr / Daappo / Barda Dcma
IncumbentParatek Pharmaceuticals, Inc
UEID5KEFN62CJ97
NAICS541714

No full NAICS 541714 intel page yet. Browse NAICS intelligence

PSC6505
Place of performanceBOSTON, MA
Related solicitation19-100-SOL-00011
PoP end (current)Dec 17, 2029
Obligated$108.7M

ANTIBIOTIC FOR TREATMENT OF A BIOTHREAT INDICATION is a federal NONE award for Department of Health and Human Services (HHS) held by Paratek Pharmaceuticals, Inc. Estimated value $265.3M ($108.7M obligated). Current period of performance ends Dec 17, 2029. Last award drew 4 bidders. Place of performance: BOSTON, MA. Related solicitation 19-100-SOL-00011.

ANTIBIOTIC FOR TREATMENT OF A BIOTHREAT INDICATION

Recompete timing

Public
Expiring in 1181 days

Current PoP ends Dec 17, 2029 (1181 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around Jun 17, 2028.

Bonuses end Sept 30

Want the durability read on 75A50120C00001? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Paratek Pharmaceuticals, Inc$40.7M obligated across 2 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)
Department of Health and Human Services (HHS)$40.7M · 100% of firm total
Open full company profile

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 75A50120C00001?

75A50120C00001 (Antibiotic for treatment of a biothreat) is a Barda - Aspr / Daappo / Barda Dcma award with an estimated value of $265.3M, currently held by Paratek Pharmaceuticals, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75A50120C00001?

Barda - Aspr / Daappo / Barda Dcma awarded 75A50120C00001 to Paratek Pharmaceuticals, Inc.

Who is the incumbent on 75A50120C00001?

Paratek Pharmaceuticals, Inc is the incumbent with $40.7M across 2 related awards in SCOUT’s public footprint. The current period of performance ends Dec 17, 2029.

When does Paratek Pharmaceuticals, Inc’s 75A50120C00001 come up for recompete?

SCOUT tracks a period-of-performance end of Dec 17, 2029. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 75A50120C00001? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75A50120C00001